Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-20721278

ABSTRACT

As part of our interest into the bioinorganic chemistry of gallium, gallium(III) complexes of the azole ligands 2,1,3-benzothiadiazole (btd), 1,2,3-benzotriazole (btaH), and 1-methyl-4,5-diphenylimidazole (L) have been isolated. Reaction of btaH or btd with GaBr(3) or GaCl(3) resulted in the mononuclear complexes [GaBr(3)(btaH)(2)] (1) and [GaCl(3)(btd)(2)] (2), respectively, while treatment of GaCl(3) with L resulted in the anionic complex (LH)(2)[GaCl(4)] (3). All three complexes were characterized by single-crystal X-ray crystallography and IR spectroscopy, while their antiproliferative activities were investigated against a series of human and mouse cancer cell lines.

2.
Cancer Lett ; 233(2): 255-64, 2006 Feb 28.
Article in English | MEDLINE | ID: mdl-15893418

ABSTRACT

Genistein, a natural isoflavone product has been shown to induce cellular death and increase the apoptotic cell death induced by several DNA-damaging stimuli. We have explored the combined effect of genistein and camptothecins against three cell lines, HeLa (cervical cancer), OAW-42 (ovarian cancer) and L929 (normal fibroblasts). Combined effect was estimated in 96-well plates using the SRB method and median-effect analysis. Addition of genistein synergistically increased the antiproliferative affect of camptothecins, inhibiting the camptothecin-induced G2/M arrest and increasing the apoptotic cell population. In HeLa cells, genistein inhibited CDK1 phosphorylation after irinotecan treatment. Thus, abrogation of the G2/M checkpoint control by genistein may be a useful maneuver to increase cytotoxicity of agents that damage DNA and inhibit cell-cycle progression in the G2/M boundary.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fibroblasts/drug effects , Ovarian Neoplasms/drug therapy , Protein-Tyrosine Kinases/antagonists & inhibitors , Apoptosis/drug effects , CDC2 Protein Kinase/metabolism , Camptothecin/administration & dosage , Cell Division/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Drug Synergism , Female , Fibroblasts/cytology , Fibroblasts/enzymology , G2 Phase/drug effects , Genistein/administration & dosage , HeLa Cells/cytology , HeLa Cells/drug effects , HeLa Cells/enzymology , Humans , In Vitro Techniques , Ovarian Neoplasms/enzymology , Ovarian Neoplasms/pathology , Phosphorylation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...